

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.72456013 |
| 2 | vocalization behavior (GO:0071625) | 5.46432491 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 5.28849593 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.24763846 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.22566868 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.19039426 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.16285261 |
| 8 | synaptic vesicle maturation (GO:0016188) | 5.11643274 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.05115965 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.93164753 |
| 11 | protein localization to synapse (GO:0035418) | 4.91449764 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.69234238 |
| 13 | glutamate secretion (GO:0014047) | 4.65312214 |
| 14 | exploration behavior (GO:0035640) | 4.58399075 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.58102593 |
| 16 | dendritic spine morphogenesis (GO:0060997) | 4.54820650 |
| 17 | neuron recognition (GO:0008038) | 4.49168634 |
| 18 | regulation of synapse structural plasticity (GO:0051823) | 4.47312284 |
| 19 | * membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.44921393 |
| 20 | axonal fasciculation (GO:0007413) | 4.43200679 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.37198770 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.34881350 |
| 23 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.25761075 |
| 24 | layer formation in cerebral cortex (GO:0021819) | 4.21967315 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.16003203 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.14775655 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 4.12258923 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.12033221 |
| 29 | neurotransmitter secretion (GO:0007269) | 4.00178041 |
| 30 | neuronal action potential propagation (GO:0019227) | 3.99099738 |
| 31 | presynaptic membrane organization (GO:0097090) | 3.95418392 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.94514258 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.89452112 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 3.76512630 |
| 35 | proline transport (GO:0015824) | 3.75907658 |
| 36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.70068359 |
| 37 | long-term memory (GO:0007616) | 3.66164929 |
| 38 | * membrane depolarization during action potential (GO:0086010) | 3.61475298 |
| 39 | startle response (GO:0001964) | 3.61190606 |
| 40 | neuromuscular synaptic transmission (GO:0007274) | 3.59997359 |
| 41 | cell migration in hindbrain (GO:0021535) | 3.55601321 |
| 42 | sodium ion export (GO:0071436) | 3.55446142 |
| 43 | innervation (GO:0060384) | 3.54388551 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 3.52520860 |
| 45 | regulation of synaptic plasticity (GO:0048167) | 3.52158244 |
| 46 | dendrite morphogenesis (GO:0048813) | 3.50191629 |
| 47 | establishment of mitochondrion localization (GO:0051654) | 3.49094528 |
| 48 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.48852663 |
| 49 | synaptic vesicle endocytosis (GO:0048488) | 3.47958421 |
| 50 | behavioral response to nicotine (GO:0035095) | 3.46476138 |
| 51 | postsynaptic membrane organization (GO:0001941) | 3.44590398 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.44115831 |
| 53 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.39427017 |
| 54 | dendritic spine organization (GO:0097061) | 3.39336541 |
| 55 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.36933931 |
| 56 | transmission of nerve impulse (GO:0019226) | 3.36591089 |
| 57 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.36090274 |
| 58 | mating behavior (GO:0007617) | 3.34216760 |
| 59 | negative regulation of microtubule polymerization (GO:0031115) | 3.33356916 |
| 60 | behavioral fear response (GO:0001662) | 3.30592068 |
| 61 | behavioral defense response (GO:0002209) | 3.30592068 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.29284894 |
| 63 | long-term synaptic potentiation (GO:0060291) | 3.28797659 |
| 64 | neurotransmitter transport (GO:0006836) | 3.27297989 |
| 65 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.26233406 |
| 66 | neuronal ion channel clustering (GO:0045161) | 3.25627644 |
| 67 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.25521655 |
| 68 | synapse assembly (GO:0007416) | 3.25242950 |
| 69 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.24926078 |
| 70 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.24680089 |
| 71 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.23631310 |
| 72 | regulation of vesicle fusion (GO:0031338) | 3.21825581 |
| 73 | auditory behavior (GO:0031223) | 3.20866262 |
| 74 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.19845400 |
| 75 | response to pheromone (GO:0019236) | 3.19053214 |
| 76 | gamma-aminobutyric acid transport (GO:0015812) | 3.19028173 |
| 77 | cerebellar granule cell differentiation (GO:0021707) | 3.18457270 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.16271127 |
| 79 | mechanosensory behavior (GO:0007638) | 3.15416420 |
| 80 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.14531041 |
| 81 | regulation of neurotransmitter secretion (GO:0046928) | 3.13140059 |
| 82 | activation of protein kinase A activity (GO:0034199) | 3.13096357 |
| 83 | learning (GO:0007612) | 3.12674291 |
| 84 | potassium ion homeostasis (GO:0055075) | 3.12415678 |
| 85 | prepulse inhibition (GO:0060134) | 3.12003736 |
| 86 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.11352492 |
| 87 | positive regulation of dendritic spine development (GO:0060999) | 3.10909416 |
| 88 | fear response (GO:0042596) | 3.10683871 |
| 89 | neuromuscular process controlling balance (GO:0050885) | 3.10482553 |
| 90 | regulation of neurotransmitter levels (GO:0001505) | 3.10131448 |
| 91 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.09174737 |
| 92 | response to auditory stimulus (GO:0010996) | 3.08470377 |
| 93 | adult walking behavior (GO:0007628) | 3.06931953 |
| 94 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.06402647 |
| 95 | dopamine receptor signaling pathway (GO:0007212) | 3.06235995 |
| 96 | regulation of synapse maturation (GO:0090128) | 3.04501299 |
| 97 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.04420444 |
| 98 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.04283599 |
| 99 | positive regulation of neurotransmitter transport (GO:0051590) | 3.03743978 |
| 100 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.03601090 |
| 101 | positive regulation of synapse assembly (GO:0051965) | 3.03125146 |
| 102 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.01517735 |
| 103 | * membrane depolarization (GO:0051899) | 3.01396333 |
| 104 | regulation of dendritic spine development (GO:0060998) | 2.98736833 |
| 105 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.97853619 |
| 106 | response to histamine (GO:0034776) | 2.97578339 |
| 107 | potassium ion import (GO:0010107) | 2.97528484 |
| 108 | presynaptic membrane assembly (GO:0097105) | 2.97102177 |
| 109 | cellular potassium ion homeostasis (GO:0030007) | 2.95868142 |
| 110 | nucleobase catabolic process (GO:0046113) | 2.95671843 |
| 111 | L-amino acid import (GO:0043092) | 2.95031766 |
| 112 | intraspecies interaction between organisms (GO:0051703) | 2.94090123 |
| 113 | social behavior (GO:0035176) | 2.94090123 |
| 114 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.92480401 |
| 115 | mitochondrion transport along microtubule (GO:0047497) | 2.92480401 |
| 116 | dendrite development (GO:0016358) | 2.91242779 |
| 117 | axon extension (GO:0048675) | 2.91017559 |
| 118 | vesicle transport along microtubule (GO:0047496) | 2.90494327 |
| 119 | regulation of neurotransmitter transport (GO:0051588) | 2.90439138 |
| 120 | regulation of synaptic transmission (GO:0050804) | 2.88440697 |
| 121 | cell communication by electrical coupling (GO:0010644) | 2.87983967 |
| 122 | serotonin metabolic process (GO:0042428) | 2.87767964 |
| 123 | synaptic transmission (GO:0007268) | 2.86643186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.73422850 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.72948934 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.17834180 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.09690893 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99303651 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75372493 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75372493 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.69594322 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.69537661 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.68505833 |
| 11 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.66832544 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.60833151 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48162451 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47448609 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45049383 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39613423 |
| 17 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.36229891 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.35501510 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29661203 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.26956616 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.26551001 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.25969666 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.24881032 |
| 24 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18391685 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03130019 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.92637419 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90792684 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82358012 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81739344 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76050268 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.74177012 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.69512645 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64204876 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.63690666 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62694896 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60766210 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.60027775 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57242877 |
| 39 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.56002874 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51827068 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49750877 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.48485984 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45968365 |
| 44 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.44996744 |
| 45 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.44688642 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.43813099 |
| 47 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.39722709 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32324775 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31338464 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30214512 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29692029 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26299907 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25428113 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24488363 |
| 55 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20802442 |
| 56 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19797417 |
| 57 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18936502 |
| 58 | AR_19668381_ChIP-Seq_PC3_Human | 1.16217311 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15714338 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15425748 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15287424 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15107141 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12690220 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12034605 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11976054 |
| 66 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11840468 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11008205 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10280277 |
| 69 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09611338 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07886084 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07749605 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06671056 |
| 73 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05573862 |
| 74 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05525264 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04101352 |
| 76 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03634048 |
| 77 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03184649 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01937359 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01520359 |
| 80 | JUN_21703547_ChIP-Seq_K562_Human | 1.01476780 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00534760 |
| 82 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00224074 |
| 83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99259405 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98803396 |
| 85 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.98640046 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.97698231 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96923221 |
| 88 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96699792 |
| 89 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96699792 |
| 90 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96554666 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96256495 |
| 92 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95090669 |
| 93 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93984758 |
| 94 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93651135 |
| 95 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.93627848 |
| 96 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93223166 |
| 97 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92977981 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92538429 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92504874 |
| 100 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92340035 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91837188 |
| 102 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91225091 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90183721 |
| 104 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90093194 |
| 105 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89823538 |
| 106 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89823538 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89740579 |
| 108 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.89683251 |
| 109 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88962501 |
| 110 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88624432 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88267679 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88145671 |
| 113 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86096209 |
| 114 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.85657859 |
| 115 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.84863336 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83770419 |
| 117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.83697531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.50161890 |
| 2 | MP0003880_abnormal_central_pattern | 5.31362221 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.07567088 |
| 4 | MP0004270_analgesia | 3.92392616 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.42155989 |
| 6 | MP0009745_abnormal_behavioral_response | 3.18977573 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.96060870 |
| 8 | MP0002822_catalepsy | 2.95187708 |
| 9 | MP0002064_seizures | 2.86046541 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.83486747 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.73408558 |
| 12 | MP0006276_abnormal_autonomic_nervous | 2.62984632 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.61680420 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.40577104 |
| 15 | MP0009046_muscle_twitch | 2.31950094 |
| 16 | MP0002272_abnormal_nervous_system | 2.31556659 |
| 17 | MP0002736_abnormal_nociception_after | 2.30184793 |
| 18 | MP0000778_abnormal_nervous_system | 2.28847639 |
| 19 | MP0001486_abnormal_startle_reflex | 2.28422301 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.23725925 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.15934988 |
| 22 | MP0002184_abnormal_innervation | 2.15192226 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.14447640 |
| 24 | MP0001984_abnormal_olfaction | 2.03640042 |
| 25 | MP0001970_abnormal_pain_threshold | 1.98647369 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.92090608 |
| 27 | MP0004858_abnormal_nervous_system | 1.90434110 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.89065993 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.84178711 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.84107085 |
| 31 | MP0001529_abnormal_vocalization | 1.78278863 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.70553629 |
| 33 | MP0003329_amyloid_beta_deposits | 1.69937662 |
| 34 | MP0004924_abnormal_behavior | 1.68774224 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.68774224 |
| 36 | MP0003122_maternal_imprinting | 1.68069060 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.62113829 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.59922608 |
| 39 | MP0000955_abnormal_spinal_cord | 1.59831578 |
| 40 | MP0001905_abnormal_dopamine_level | 1.56276665 |
| 41 | MP0008569_lethality_at_weaning | 1.49102238 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.48397052 |
| 43 | MP0001188_hyperpigmentation | 1.45629386 |
| 44 | MP0003787_abnormal_imprinting | 1.39020146 |
| 45 | MP0002066_abnormal_motor_capabilities/c | 1.36289712 |
| 46 | MP0008877_abnormal_DNA_methylation | 1.32887628 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.32784459 |
| 48 | MP0005394_taste/olfaction_phenotype | 1.31294141 |
| 49 | MP0005499_abnormal_olfactory_system | 1.31294141 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.21421769 |
| 51 | MP0003123_paternal_imprinting | 1.19938724 |
| 52 | MP0002152_abnormal_brain_morphology | 1.18353037 |
| 53 | MP0003879_abnormal_hair_cell | 1.18227930 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.15742630 |
| 55 | MP0004885_abnormal_endolymph | 1.11723688 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.10865002 |
| 57 | MP0003633_abnormal_nervous_system | 1.06554436 |
| 58 | MP0000751_myopathy | 1.03753725 |
| 59 | MP0004742_abnormal_vestibular_system | 1.00491748 |
| 60 | MP0002069_abnormal_eating/drinking_beha | 0.97225442 |
| 61 | MP0003631_nervous_system_phenotype | 0.94773687 |
| 62 | MP0004142_abnormal_muscle_tone | 0.94471471 |
| 63 | MP0002102_abnormal_ear_morphology | 0.93113495 |
| 64 | MP0001485_abnormal_pinna_reflex | 0.92756851 |
| 65 | MP0008872_abnormal_physiological_respon | 0.92721237 |
| 66 | MP0000631_abnormal_neuroendocrine_gland | 0.91859515 |
| 67 | MP0003690_abnormal_glial_cell | 0.91650854 |
| 68 | MP0002638_abnormal_pupillary_reflex | 0.88726175 |
| 69 | MP0005409_darkened_coat_color | 0.87670919 |
| 70 | MP0002752_abnormal_somatic_nervous | 0.84601250 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 0.84573622 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 0.84109883 |
| 73 | MP0000920_abnormal_myelination | 0.83697410 |
| 74 | MP0002751_abnormal_autonomic_nervous | 0.82015171 |
| 75 | MP0004085_abnormal_heartbeat | 0.80482638 |
| 76 | MP0003634_abnormal_glial_cell | 0.80008336 |
| 77 | MP0001177_atelectasis | 0.79279145 |
| 78 | MP0005535_abnormal_body_temperature | 0.78447901 |
| 79 | MP0004133_heterotaxia | 0.78354750 |
| 80 | MP0002229_neurodegeneration | 0.77357616 |
| 81 | MP0003861_abnormal_nervous_system | 0.76157033 |
| 82 | MP0008874_decreased_physiological_sensi | 0.75990249 |
| 83 | MP0001963_abnormal_hearing_physiology | 0.74593332 |
| 84 | MP0004130_abnormal_muscle_cell | 0.72269314 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.71654655 |
| 86 | MP0004147_increased_porphyrin_level | 0.71023952 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 0.68201092 |
| 88 | MP0004043_abnormal_pH_regulation | 0.67801125 |
| 89 | MP0005253_abnormal_eye_physiology | 0.66772247 |
| 90 | MP0000604_amyloidosis | 0.65751118 |
| 91 | MP0003632_abnormal_nervous_system | 0.65034476 |
| 92 | MP0001664_abnormal_digestion | 0.64864675 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.63985132 |
| 94 | MP0003121_genomic_imprinting | 0.63601048 |
| 95 | MP0002653_abnormal_ependyma_morphology | 0.63484522 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.63404297 |
| 97 | MP0003283_abnormal_digestive_organ | 0.57392229 |
| 98 | MP0000534_abnormal_ureter_morphology | 0.57260882 |
| 99 | MP0001943_abnormal_respiration | 0.57125495 |
| 100 | MP0005187_abnormal_penis_morphology | 0.57050897 |
| 101 | MP0001299_abnormal_eye_distance/ | 0.56835650 |
| 102 | MP0004233_abnormal_muscle_weight | 0.55660544 |
| 103 | MP0000026_abnormal_inner_ear | 0.54423566 |
| 104 | MP0002234_abnormal_pharynx_morphology | 0.54332695 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.53722575 |
| 106 | MP0002082_postnatal_lethality | 0.52913584 |
| 107 | MP0010770_preweaning_lethality | 0.52913584 |
| 108 | MP0003075_altered_response_to | 0.52850522 |
| 109 | MP0010769_abnormal_survival | 0.52393672 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.51881366 |
| 111 | MP0004484_altered_response_of | 0.51641167 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.51574074 |
| 113 | MP0010768_mortality/aging | 0.49184217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.17420544 |
| 2 | Myokymia (HP:0002411) | 6.89283471 |
| 3 | Focal seizures (HP:0007359) | 5.68115029 |
| 4 | Visual hallucinations (HP:0002367) | 4.80289818 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.32233850 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.08856799 |
| 7 | Limb dystonia (HP:0002451) | 4.00998880 |
| 8 | Febrile seizures (HP:0002373) | 3.99761974 |
| 9 | Atonic seizures (HP:0010819) | 3.88537275 |
| 10 | Absence seizures (HP:0002121) | 3.69029997 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.65901909 |
| 12 | Action tremor (HP:0002345) | 3.60995198 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.49302153 |
| 14 | Dialeptic seizures (HP:0011146) | 3.47557830 |
| 15 | Amblyopia (HP:0000646) | 3.42860626 |
| 16 | Broad-based gait (HP:0002136) | 3.39117643 |
| 17 | Ankle clonus (HP:0011448) | 3.35231262 |
| 18 | Mutism (HP:0002300) | 3.32042776 |
| 19 | Hyperventilation (HP:0002883) | 3.25777082 |
| 20 | Drooling (HP:0002307) | 3.18557982 |
| 21 | Excessive salivation (HP:0003781) | 3.18557982 |
| 22 | Poor eye contact (HP:0000817) | 3.03898730 |
| 23 | Abnormal eating behavior (HP:0100738) | 2.98613786 |
| 24 | Polyphagia (HP:0002591) | 2.98460364 |
| 25 | Papilledema (HP:0001085) | 2.97057455 |
| 26 | Depression (HP:0000716) | 2.95810636 |
| 27 | Cerebral inclusion bodies (HP:0100314) | 2.93024179 |
| 28 | Truncal ataxia (HP:0002078) | 2.87597603 |
| 29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.86373385 |
| 30 | Anxiety (HP:0000739) | 2.81044630 |
| 31 | Status epilepticus (HP:0002133) | 2.80571047 |
| 32 | Neurofibrillary tangles (HP:0002185) | 2.76778605 |
| 33 | Abnormal social behavior (HP:0012433) | 2.73106799 |
| 34 | Impaired social interactions (HP:0000735) | 2.73106799 |
| 35 | Torticollis (HP:0000473) | 2.72699123 |
| 36 | Progressive inability to walk (HP:0002505) | 2.67490935 |
| 37 | Dysmetria (HP:0001310) | 2.63939752 |
| 38 | Focal dystonia (HP:0004373) | 2.55060719 |
| 39 | Failure to thrive in infancy (HP:0001531) | 2.52962510 |
| 40 | Genetic anticipation (HP:0003743) | 2.51152769 |
| 41 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.51046784 |
| 42 | Insidious onset (HP:0003587) | 2.50076759 |
| 43 | Termporal pattern (HP:0011008) | 2.50076759 |
| 44 | Dysdiadochokinesis (HP:0002075) | 2.49947431 |
| 45 | Hemiparesis (HP:0001269) | 2.49052779 |
| 46 | Urinary urgency (HP:0000012) | 2.48812368 |
| 47 | Amyotrophic lateral sclerosis (HP:0007354) | 2.44437381 |
| 48 | Postural instability (HP:0002172) | 2.43863306 |
| 49 | Abnormality of the lower motor neuron (HP:0002366) | 2.42408095 |
| 50 | Hemiplegia (HP:0002301) | 2.41464849 |
| 51 | Epileptiform EEG discharges (HP:0011182) | 2.41386673 |
| 52 | Cerebral hypomyelination (HP:0006808) | 2.41287707 |
| 53 | Gaze-evoked nystagmus (HP:0000640) | 2.39487388 |
| 54 | Absent speech (HP:0001344) | 2.37993412 |
| 55 | Impaired smooth pursuit (HP:0007772) | 2.36121404 |
| 56 | Exotropia (HP:0000577) | 2.33443840 |
| 57 | Bradykinesia (HP:0002067) | 2.33395556 |
| 58 | Fetal akinesia sequence (HP:0001989) | 2.32358022 |
| 59 | Stereotypic behavior (HP:0000733) | 2.30553391 |
| 60 | Craniofacial dystonia (HP:0012179) | 2.30404188 |
| 61 | Agitation (HP:0000713) | 2.30142726 |
| 62 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.29258491 |
| 63 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.28224393 |
| 64 | Hypoplasia of the brainstem (HP:0002365) | 2.28224393 |
| 65 | Spastic tetraplegia (HP:0002510) | 2.26356623 |
| 66 | Pheochromocytoma (HP:0002666) | 2.25414901 |
| 67 | Inability to walk (HP:0002540) | 2.24912993 |
| 68 | EEG with generalized epileptiform discharges (HP:0011198) | 2.24491406 |
| 69 | Spastic gait (HP:0002064) | 2.24469815 |
| 70 | Abnormality of binocular vision (HP:0011514) | 2.23447021 |
| 71 | Diplopia (HP:0000651) | 2.23447021 |
| 72 | Abnormality of salivation (HP:0100755) | 2.20932311 |
| 73 | Gait imbalance (HP:0002141) | 2.19122730 |
| 74 | Hypsarrhythmia (HP:0002521) | 2.13814458 |
| 75 | Hypoventilation (HP:0002791) | 2.11218723 |
| 76 | Lower limb muscle weakness (HP:0007340) | 2.11034878 |
| 77 | Specific learning disability (HP:0001328) | 2.07665820 |
| 78 | Inappropriate behavior (HP:0000719) | 2.05773559 |
| 79 | Abnormality of the corticospinal tract (HP:0002492) | 2.04653369 |
| 80 | Megalencephaly (HP:0001355) | 2.04243891 |
| 81 | Pachygyria (HP:0001302) | 2.03059993 |
| 82 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.02099201 |
| 83 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.02099201 |
| 84 | Akinesia (HP:0002304) | 2.00472393 |
| 85 | Blue irides (HP:0000635) | 2.00133032 |
| 86 | Prolonged QT interval (HP:0001657) | 1.99529488 |
| 87 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99319277 |
| 88 | Scanning speech (HP:0002168) | 1.97173389 |
| 89 | Insomnia (HP:0100785) | 1.96815658 |
| 90 | Spastic tetraparesis (HP:0001285) | 1.93630164 |
| 91 | Protruding tongue (HP:0010808) | 1.92930766 |
| 92 | Sleep apnea (HP:0010535) | 1.91699195 |
| 93 | Apathy (HP:0000741) | 1.91541049 |
| 94 | Incomplete penetrance (HP:0003829) | 1.90580753 |
| 95 | Muscular hypotonia of the trunk (HP:0008936) | 1.90193210 |
| 96 | Abnormality of the labia minora (HP:0012880) | 1.90127364 |
| 97 | Impaired vibratory sensation (HP:0002495) | 1.90008429 |
| 98 | Anosmia (HP:0000458) | 1.88846600 |
| 99 | Neuroendocrine neoplasm (HP:0100634) | 1.85621308 |
| 100 | Lissencephaly (HP:0001339) | 1.85142108 |
| 101 | Poor suck (HP:0002033) | 1.84878704 |
| 102 | Intellectual disability, severe (HP:0010864) | 1.84861764 |
| 103 | Pointed chin (HP:0000307) | 1.83807996 |
| 104 | Rapidly progressive (HP:0003678) | 1.83733445 |
| 105 | Hypoplasia of the corpus callosum (HP:0002079) | 1.83707362 |
| 106 | Clonus (HP:0002169) | 1.83207582 |
| 107 | Intention tremor (HP:0002080) | 1.81322064 |
| 108 | Congenital stationary night blindness (HP:0007642) | 1.78468170 |
| 109 | Esotropia (HP:0000565) | 1.77601619 |
| 110 | Gait ataxia (HP:0002066) | 1.77266994 |
| 111 | Ventricular fibrillation (HP:0001663) | 1.77010288 |
| 112 | Type II lissencephaly (HP:0007260) | 1.76539596 |
| 113 | Autism (HP:0000717) | 1.75272162 |
| 114 | Delusions (HP:0000746) | 1.75002978 |
| 115 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.74985097 |
| 116 | Syncope (HP:0001279) | 1.74405851 |
| 117 | Abnormality of pain sensation (HP:0010832) | 1.74331509 |
| 118 | Impaired pain sensation (HP:0007328) | 1.74331509 |
| 119 | Nephronophthisis (HP:0000090) | 1.73483026 |
| 120 | Generalized myoclonic seizures (HP:0002123) | 1.72208260 |
| 121 | Dyskinesia (HP:0100660) | 1.69909643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.50093399 |
| 2 | NTRK3 | 4.39153105 |
| 3 | EPHA4 | 4.12408307 |
| 4 | MAP3K9 | 3.52604661 |
| 5 | MINK1 | 3.03388937 |
| 6 | MAP3K4 | 2.81786993 |
| 7 | NTRK2 | 2.70344544 |
| 8 | KSR1 | 2.50515939 |
| 9 | MAP2K7 | 2.46681703 |
| 10 | NTRK1 | 2.40860311 |
| 11 | DAPK2 | 2.25351038 |
| 12 | SIK3 | 2.16737760 |
| 13 | MAP3K12 | 1.98606284 |
| 14 | PAK6 | 1.91982680 |
| 15 | KSR2 | 1.82314935 |
| 16 | RIPK4 | 1.82239666 |
| 17 | MAPK13 | 1.74250130 |
| 18 | CASK | 1.73397553 |
| 19 | MAP2K4 | 1.73319121 |
| 20 | DAPK1 | 1.60141078 |
| 21 | CDK5 | 1.57854126 |
| 22 | SIK2 | 1.53545956 |
| 23 | PRPF4B | 1.42772790 |
| 24 | GRK5 | 1.42282232 |
| 25 | PRKD3 | 1.41689728 |
| 26 | UHMK1 | 1.39526887 |
| 27 | TNIK | 1.36518686 |
| 28 | PLK2 | 1.35247691 |
| 29 | FRK | 1.34405700 |
| 30 | PHKG2 | 1.29660282 |
| 31 | PHKG1 | 1.29660282 |
| 32 | ARAF | 1.24324559 |
| 33 | CAMKK1 | 1.24182027 |
| 34 | PNCK | 1.22863278 |
| 35 | BCR | 1.17333282 |
| 36 | PRKCG | 1.14367307 |
| 37 | WNK3 | 1.13785857 |
| 38 | LATS2 | 1.07302123 |
| 39 | CDK18 | 1.06192969 |
| 40 | FES | 1.04571256 |
| 41 | CAMK2A | 1.04251934 |
| 42 | CAMK2B | 1.01698779 |
| 43 | TYRO3 | 0.96493860 |
| 44 | PTK2B | 0.95149073 |
| 45 | CDK15 | 0.94623473 |
| 46 | PKN1 | 0.93870466 |
| 47 | CDK14 | 0.93586504 |
| 48 | CSNK1G2 | 0.92440503 |
| 49 | MAP3K2 | 0.90888929 |
| 50 | EPHB2 | 0.90138335 |
| 51 | MAP4K2 | 0.89505472 |
| 52 | SGK494 | 0.84834464 |
| 53 | SGK223 | 0.84834464 |
| 54 | STK38 | 0.84051759 |
| 55 | CDK11A | 0.82171982 |
| 56 | PAK3 | 0.81467449 |
| 57 | MAPK12 | 0.81409024 |
| 58 | BMPR2 | 0.80375264 |
| 59 | RET | 0.80232692 |
| 60 | ADRBK2 | 0.78641732 |
| 61 | DYRK1A | 0.78344704 |
| 62 | SGK2 | 0.71627296 |
| 63 | ERBB3 | 0.70677382 |
| 64 | RAF1 | 0.69014621 |
| 65 | DYRK2 | 0.68339108 |
| 66 | NME1 | 0.67843293 |
| 67 | CAMK4 | 0.67499824 |
| 68 | CDK19 | 0.66742375 |
| 69 | MARK2 | 0.65724286 |
| 70 | MAP3K13 | 0.64945561 |
| 71 | PRKCZ | 0.63198445 |
| 72 | LMTK2 | 0.63170769 |
| 73 | WNK4 | 0.62700006 |
| 74 | LIMK1 | 0.62084038 |
| 75 | CAMK1 | 0.61381890 |
| 76 | SGK1 | 0.55614097 |
| 77 | STK11 | 0.55306678 |
| 78 | FER | 0.54160895 |
| 79 | GRK7 | 0.52935414 |
| 80 | MAP3K11 | 0.52750238 |
| 81 | CSNK1G1 | 0.52130448 |
| 82 | CSNK1G3 | 0.52038709 |
| 83 | FGR | 0.51652386 |
| 84 | PRKCE | 0.50825977 |
| 85 | PRKCH | 0.50475847 |
| 86 | FYN | 0.50399212 |
| 87 | CAMK2D | 0.50356484 |
| 88 | SGK3 | 0.47480742 |
| 89 | RPS6KA2 | 0.46272572 |
| 90 | PRKG1 | 0.44825623 |
| 91 | MAP2K1 | 0.44786520 |
| 92 | PRKACA | 0.43935088 |
| 93 | BMPR1B | 0.43217691 |
| 94 | GRK1 | 0.42811635 |
| 95 | ADRBK1 | 0.41004974 |
| 96 | MAP2K6 | 0.40145828 |
| 97 | INSRR | 0.40034842 |
| 98 | TRIM28 | 0.39949187 |
| 99 | PDK1 | 0.38672525 |
| 100 | RPS6KA3 | 0.38375026 |
| 101 | PRKCA | 0.37884138 |
| 102 | CSNK1E | 0.37318061 |
| 103 | CAMKK2 | 0.36833238 |
| 104 | CAMK2G | 0.35878093 |
| 105 | MAPK10 | 0.35691086 |
| 106 | CSNK1A1 | 0.35510100 |
| 107 | CSNK1D | 0.35442028 |
| 108 | STK39 | 0.34988813 |
| 109 | TAOK3 | 0.34948149 |
| 110 | ERBB2 | 0.33339386 |
| 111 | PDPK1 | 0.32194128 |
| 112 | AKT3 | 0.32089974 |
| 113 | FGFR2 | 0.31586167 |
| 114 | ALK | 0.30892621 |
| 115 | PINK1 | 0.30874127 |
| 116 | CSNK1A1L | 0.30477786 |
| 117 | TAOK1 | 0.29710957 |
| 118 | CCNB1 | 0.29578012 |
| 119 | MAP3K6 | 0.29565084 |
| 120 | BRAF | 0.28944043 |
| 121 | PRKCB | 0.28903242 |
| 122 | MAPK8 | 0.28612099 |
| 123 | CAMK1G | 0.27706722 |
| 124 | MAPKAPK5 | 0.27418509 |
| 125 | OXSR1 | 0.27338873 |
| 126 | MAP3K1 | 0.27039259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.80051077 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.12743219 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.87744954 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.71609399 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.68149575 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.65091824 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.61510379 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.55471860 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.52902585 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.41682821 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.38499958 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.10828102 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.07342954 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.98952701 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.87449457 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.87397939 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.87135997 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.78858172 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75629653 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73550181 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.68011074 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.63623654 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61548300 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60416890 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59730743 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.56054968 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.52757985 |
| 28 | Gap junction_Homo sapiens_hsa04540 | 1.49001113 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47172430 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42637583 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40264808 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34162719 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.23211228 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20467382 |
| 35 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.16406401 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14441408 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12789564 |
| 38 | Melanogenesis_Homo sapiens_hsa04916 | 1.10719252 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08263004 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08203239 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05350271 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96166657 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93808655 |
| 44 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92201255 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.91740488 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90763445 |
| 47 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.90591937 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82464101 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82337899 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82054305 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81333346 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80006661 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79141840 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78389060 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76650385 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76082623 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72516977 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71422805 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71337967 |
| 60 | Alcoholism_Homo sapiens_hsa05034 | 0.71217516 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69281150 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67602503 |
| 63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66367386 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66170517 |
| 65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65188576 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63719731 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63135198 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62630127 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61146287 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60405009 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59745264 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57075397 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54710310 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54601224 |
| 75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54055522 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54014332 |
| 77 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52795751 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51970646 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51154673 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50877316 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50520990 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49960440 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49437094 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.49305746 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49138043 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.48102548 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47300289 |
| 88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46799224 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46479934 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46308832 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45253766 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44168583 |
| 93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41128373 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41004883 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40840269 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40271457 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39119205 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38651462 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36902431 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36869619 |
| 101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36014296 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35951739 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35801094 |
| 104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35528781 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34678447 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33032223 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32291565 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30684345 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.29061723 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28927764 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26627785 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26470198 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26384135 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26366439 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25949727 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.25030628 |
| 117 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.24743697 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23738680 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21492731 |
| 120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.21342765 |

